Zacks Research Has Bullish Estimate for Docusign Q3 Earnings

Docusign Inc. (NASDAQ:DOCU) – Equities researchers at Zacks Research upped their Q3 2027 earnings per share (EPS) estimates for shares of Docusign in a research note issued to investors on Thursday, September 24th. Zacks Research analyst Team now forecasts that the company will post earnings of $0.43 per share for the quarter, up from their previous forecast of $0.41. The consensus estimate for Docusign’s current full-year earnings is $2.13 per share.

Other analysts also recently issued reports about the company. Morgan Stanley raised their price objective on Docusign from $69.00 to $75.00 and gave the stock an “equal weight” rating in a research report on Friday, September 4th. Royal Bank Of Canada boosted their price target on shares of Docusign from $55.00 to $70.00 and gave the company a “sector perform” rating in a research note on Friday, September 4th. Weiss Ratings raised shares of Docusign from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, August 25th. BTIG Research lifted their target price on shares of Docusign from $60.00 to $75.00 and gave the company a “buy” rating in a report on Wednesday, September 2nd. Finally, Piper Sandler upped their price target on Docusign from $52.00 to $75.00 and gave the stock a “neutral” rating in a research note on Friday, September 4th. Three equities research analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $67.33.

Docusign Price Performance

NASDAQ:DOCU opened at $66.98 on Monday. Docusign has a 52 week low of $40.16 and a 52 week high of $81.88. The stock’s fifty day moving average is $62.31 and its two-hundred day moving average is $52.56. The company has a market capitalization of $12.52 billion, a P/E ratio of 40.84, a P/E/G ratio of 2.48 and a beta of 0.90.

Docusign (NASDAQ:DOCU) last posted its earnings results on Thursday, September 3rd. The company reported $1.16 earnings per share for the quarter, beating the consensus estimate of $1.09 by $0.07. The company had revenue of $875.75 million for the quarter, compared to analyst estimates of $867.22 million. Docusign had a net margin of 9.82% and a return on equity of 18.29%. Docusign’s revenue was up 9.4% on a year-over-year basis. During the same period in the previous year, the business posted $0.30 EPS.

Insider Transactions at Docusign

In related news, Director Anna Marrs sold 548 shares of the business’s stock in a transaction on Monday, September 14th. The shares were sold at an average price of $67.00, for a total transaction of $36,716.00. Following the completion of the transaction, the director owned 13,525 shares in the company, valued at approximately $906,175. The trade was a 3.89% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Mary Wilderotter sold 1,096 shares of the stock in a transaction dated Wednesday, September 16th. The shares were sold at an average price of $70.60, for a total value of $77,377.60. Following the completion of the transaction, the director owned 3,199 shares in the company, valued at approximately $225,849.40. The trade was a 25.52% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 123,318 shares of company stock valued at $8,181,555 in the last 90 days. Insiders own 0.59% of the company’s stock.

Institutional Trading of Docusign

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Greenwich Wealth Management LLC lifted its holdings in shares of Docusign by 30.0% in the 2nd quarter. Greenwich Wealth Management LLC now owns 120,835 shares of the company’s stock valued at $5,367,000 after purchasing an additional 27,855 shares during the last quarter. QRG Capital Management Inc. boosted its position in shares of Docusign by 31.2% in the 2nd quarter. QRG Capital Management Inc. now owns 11,132 shares of the company’s stock valued at $495,000 after purchasing an additional 2,645 shares during the period. Envestnet Portfolio Solutions Inc. grew its stake in Docusign by 3.1% during the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 11,867 shares of the company’s stock worth $527,000 after buying an additional 356 shares during the last quarter. Integrated Wealth Concepts LLC increased its position in Docusign by 2.0% during the second quarter. Integrated Wealth Concepts LLC now owns 14,359 shares of the company’s stock worth $638,000 after buying an additional 277 shares during the period. Finally, NewEdge Advisors LLC lifted its stake in Docusign by 29.8% in the second quarter. NewEdge Advisors LLC now owns 14,311 shares of the company’s stock valued at $636,000 after buying an additional 3,287 shares during the last quarter. Institutional investors and hedge funds own 77.64% of the company’s stock.

Docusign News Summary

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: Improved long-term earnings outlook: Zacks Research raised its FY2027 EPS estimate to $1.96 from $1.69, FY2028 to $2.07 from $1.76, and FY2029 to $1.95 from $1.35. The revisions suggest analysts see stronger profitability ahead. Docusign Stock Earnings Estimates Lifted by Zacks Research
• Positive Sentiment: Several quarterly estimates were increased: Zacks lifted estimates for Q1 2028 EPS to $0.49 from $0.47, Q2 2028 to $0.49 from $0.28, Q3 2028 to $0.51 from $0.38, and Q2 2029 to $0.67 from $0.21. The broad upward revisions may support investor confidence in Docusign’s earnings trajectory. DOCU Stock Soars 50.8% in 3 Months
• Positive Sentiment: Operating performance remains a catalyst: The recent rally reflects expectations that customer expansion, cost discipline and cash generation can drive margin gains and fund buybacks. Docusign’s latest reported quarter also exceeded revenue and EPS expectations, with revenue up 9.4% year over year.
• Neutral Sentiment: Mixed estimate revisions: Zacks reduced its Q1 2029 EPS forecast to $0.66 from $0.73 and Q4 2028 to $0.57 from $0.62. However, these cuts were offset by increases elsewhere, while the current-year consensus remains $2.10 per share.

Docusign Company Profile

DocuSign, Inc (NASDAQ:DOCU) provides cloud-based software for electronically signing, managing and automating agreements. Its platform enables individuals and organizations to prepare, send, sign, track and store documents digitally, helping replace paper-based contracting processes.

The company’s offerings include electronic signature tools, contract lifecycle management, identity verification and authentication services, document generation, agreement analytics and related workflow automation capabilities.